{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T10:51:01Z","timestamp":1763808661218},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,1,13]],"date-time":"2007-01-13T00:00:00Z","timestamp":1168646400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2007,3,13]]},"DOI":"10.1007\/s11239-006-9049-9","type":"journal-article","created":{"date-parts":[[2007,1,16]],"date-time":"2007-01-16T19:55:57Z","timestamp":1168977357000},"page":"93-100","source":"Crossref","is-referenced-by-count":13,"title":["Heparin resistance in acute coronary syndromes"],"prefix":"10.1007","volume":"23","author":[{"given":"Jonathan D.","family":"Rich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Maraganore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa-Maria","family":"Lidon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burt","family":"Adelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Bourdon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supoat","family":"Charenkavanich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Hirsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Theroux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher P.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,1,13]]},"reference":[{"issue":"22","key":"9049_CR1","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199105303242206","volume":"324","author":"J Hirsh","year":"1991","unstructured":"Hirsh J (1991) Heparin. The New England J Med 324(22):1565\u20131574","journal-title":"The New England J Med"},{"issue":"6","key":"9049_CR2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1055\/s-0038-1648515","volume":"67","author":"E Young","year":"1992","unstructured":"Young E, Prins M, Levine MN, Hirsh J (1992) Heparin binding to plasma proteins, an important mechanism for heparin resistance. Thromb Haemostasis 67(6):639\u2013643","journal-title":"Thromb Haemostasis"},{"issue":"3 suppl","key":"9049_CR3","doi-asserted-by":"crossref","first-page":"311S","DOI":"10.1378\/chest.126.3_suppl.311S","volume":"126","author":"TE Warkentin","year":"2004","unstructured":"Warkentin TE, Greinacher A (2004) Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126(3 suppl):311S\u2013337S","journal-title":"Chest"},{"issue":"1","key":"9049_CR4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/(SICI)1096-8652(199805)58:1<24::AID-AJH5>3.0.CO;2-2","volume":"58","author":"MK Horne 3rd","year":"1998","unstructured":"Horne MK 3rd, Hutchison KJ (1998) Simultaneous binding of heparin and platelet factor\u20134 to platelets: further insights into the mechanism of heparin-induced thrombocytopenia. Am J Hematol 58(1):24\u201330","journal-title":"Am J Hematol"},{"issue":"3","key":"9049_CR5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1055\/s-0038-1642434","volume":"71","author":"E Young","year":"1994","unstructured":"Young E, Wells P, Holloway S, Weitz J, Hirsh J (1994) Ex-vivo and in-vitro evidence that low molecular weight heparins exhibit less binding to plasma proteins than unfractionated heparin. Thrombosis Haemostasis 71(3):300\u2013304","journal-title":"Thrombosis Haemostasis"},{"issue":"14","key":"9049_CR6","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa060898","volume":"354","author":"EM Antman","year":"2006","unstructured":"Antman EM, Morrow DA, McCabe CH, Murphy SA, Ruda M, Sadowski Z, Budaj A, Lopez-Sendon JL, Guneri S, Jiang F, White HD, Fox KA, Braunwald E (2006) Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. The New England J Med 354(14):1477\u20131488","journal-title":"The New England J Med"},{"issue":"5","key":"9049_CR7","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/01.CIR.94.5.911","volume":"94","author":"EM Antman","year":"1996","unstructured":"Antman EM (1996) Hirudin in acute myocardial infarction. Thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9B trial. Circulation 94(5):911\u2013921","journal-title":"Circulation"},{"issue":"10","key":"9049_CR8","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/0002-9149(93)90823-U","volume":"71","author":"CP Cannon","year":"1993","unstructured":"Cannon CP, Maraganore JM, Loscalzo J, McAllister A, Eddings K, George D, Selwyn AP, Adelman B, Fox I, Braunwald E et al (1993) Anticoagulant effects of hirulog, a novel thrombin inhibitor, in patients with coronary artery disease. Am J Cardiol 71(10):778\u2013782","journal-title":"Am J Cardiol"},{"issue":"1","key":"9049_CR9","first-page":"26","volume":"22","author":"JJ Ferguson","year":"1995","unstructured":"Ferguson JJ (1995) Recent advances in the treatment of acute myocardial infarction. Texas Heart Inst J\/Texas Heart Inst St 22(1):26\u201332","journal-title":"Texas Heart Inst J\/Texas Heart Inst St"},{"issue":"2","key":"9049_CR10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0038-1651573","volume":"69","author":"I Fox","year":"1993","unstructured":"Fox I, Dawson A, Loynds P, Eisner J, Findlen K, Levin E, Hanson D, Mant T, Wagner J, Maraganore J (1993) Anticoagulant activity of Hirulog, a direct thrombin inhibitor, in humans. Thromb Haemostasis 69(2):157\u2013163","journal-title":"Thromb Haemostasis"},{"issue":"30","key":"9049_CR11","doi-asserted-by":"crossref","first-page":"7095","DOI":"10.1021\/bi00482a021","volume":"29","author":"JM Maraganore","year":"1990","unstructured":"Maraganore JM, Bourdon P, Jablonski J, Ramachandran KL, Fenton JW 2nd (1990) Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin. Biochemistry 29(30):7095\u20137101","journal-title":"Biochemistry"},{"key":"9049_CR12","doi-asserted-by":"crossref","unstructured":"A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. The global use of strategies to open occluded coronary arteries (GUSTO) IIb investigators. The New England J Med 335(11):775\u2013782 (1996)","DOI":"10.1056\/NEJM199609123351103"},{"issue":"14","key":"9049_CR13","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa055443","volume":"354","author":"S Yusuf","year":"2006","unstructured":"Yusuf S, Mehta SR, Chrolavicius S, Afzal R, Pogue J, Granger CB, Budaj A, Peters RJ, Bassand JP, Wallentin L, Joyner C, Fox KA (2006) Comparison of fondaparinux and enoxaparin in acute coronary syndromes. The New England J Med 354(14):1464\u20131476","journal-title":"The New England J Med"},{"issue":"1","key":"9049_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V79.1.1.1","volume":"79","author":"J Hirsh","year":"1992","unstructured":"Hirsh J, Levine MN (1992) Low molecular weight heparin. Blood 79(1):1\u201317","journal-title":"Blood"},{"issue":"20","key":"9049_CR15","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","volume":"332","author":"TE Warkentin","year":"1995","unstructured":"Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG (1995) Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. The New England J Med 332(20):1330\u20131335","journal-title":"The New England J Med"},{"issue":"10","key":"9049_CR16","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMra044440","volume":"353","author":"M Di Nisio","year":"2005","unstructured":"Di Nisio M, Middeldorp S, Buller HR (2005) Direct thrombin inhibitors. The New England J Med 353(10):1028\u20131040","journal-title":"The New England J Med"},{"issue":"8","key":"9049_CR17","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1161\/01.ATV.17.8.1568","volume":"17","author":"E Young","year":"1997","unstructured":"Young E, Podor TJ, Venner T, Hirsh J (1997) Induction of the acute-phase reaction increases heparin-binding proteins in plasma. Arteriosclerosis Thromb Vascular Biol 17(8):1568\u20131574","journal-title":"Arteriosclerosis Thromb Vascular Biol"},{"issue":"3","key":"9049_CR18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1042\/bj1970599","volume":"197","author":"B Casu","year":"1981","unstructured":"Casu B, Oreste P, Torri G, Zoppetti G, Choay J, Lormeau JC, Petitou M, Sinay P (1981) The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies. Biochem J 197(3):599\u2013609","journal-title":"Biochem J"},{"issue":"3","key":"9049_CR19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0049-3848(77)90150-5","volume":"10","author":"AN Teien","year":"1977","unstructured":"Teien AN, Lie M (1977) Evaluation of an amidolytic heparin assay method: increased sensitivity by adding purified antithrombin III. Thromb Res 10(3):399\u2013410","journal-title":"Thromb Res"},{"issue":"3B","key":"9049_CR20","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/0002-9343(89)80523-6","volume":"87","author":"RD Rosenberg","year":"1989","unstructured":"Rosenberg RD (1989) Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism. Am J Med 87(3B):2S\u20139S","journal-title":"Am J Med"},{"issue":"24","key":"9049_CR21","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1161\/01.CIR.103.24.2994","volume":"103","author":"J Hirsh","year":"2001","unstructured":"Hirsh J, Anand SS, Halperin JL, Fuster V (2001) Guide to anticoagulant therapy: heparin : a statement for healthcare professionals from the American Heart Association. Circulation 103(24):2994\u20133018","journal-title":"Circulation"},{"issue":"6","key":"9049_CR22","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/0002-8703(92)90793-U","volume":"123","author":"TF McGarry Jr","year":"1992","unstructured":"McGarry TF Jr, Gottlieb RS, Morganroth J, Zelenkofske SL, Kasparian H, Duca PR, Lester RM, Kreulen TH (1992) The relationship of anticoagulation level and complications after successful percutaneous transluminal coronary angioplasty. Am Heart J 123(6):1445\u20131451","journal-title":"Am Heart J"},{"issue":"1","key":"9049_CR23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archinte.1994.00420010073009","volume":"154","author":"MN Levine","year":"1994","unstructured":"Levine MN, Hirsh J, Gent M, Turpie AG, Cruickshank M, Weitz J, Anderson D, Johnson M (1994) A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. Arch Int Med 154(1):49\u201356","journal-title":"Arch Int Med"},{"issue":"1","key":"9049_CR24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0002-8703(99)70460-6","volume":"137","author":"RC Becker","year":"1999","unstructured":"Becker RC, Ball SP, Eisenberg P, Borzak S, Held AC, Spencer F, Voyce SJ, Jesse R, Hendel R, Ma Y, Hurley T, Hebert J (1999) A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease. Antithrombotic Therapy Consortium Investigators. Am Heart J 137(1):59\u201371","journal-title":"Am Heart J"},{"issue":"2 Pt 1","key":"9049_CR25","first-page":"313","volume":"138","author":"JS Hochman","year":"1999","unstructured":"Hochman JS, Wali AU, Gavrila D, Sim MJ, Malhotra S, Palazzo AM, De La Fuente B (1999) A new regimen for heparin use in acute coronary syndromes. Am Heart J 138(2 Pt 1):313\u2013318","journal-title":"Am Heart J"},{"issue":"5","key":"9049_CR26","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1161\/01.CIR.86.5.1370","volume":"86","author":"C Kroon","year":"1992","unstructured":"Kroon C, ten Hove WR, de Boer A, Kroon JM, van der Pol JM, Harthoorn-Lasthuizen EJ, Schoemaker HC, van der Meer FJ, Cohen AF (1992) Highly variable anticoagulant response after subcutaneous administration of high-dose (12,500 IU) heparin in patients with myocardial infarction and healthy volunteers. Circulation 86(5):1370\u20131375","journal-title":"Circulation"},{"issue":"24","key":"9049_CR27","doi-asserted-by":"crossref","first-page":"14891","DOI":"10.1016\/S0021-9258(18)33366-0","volume":"257","author":"ST Olson","year":"1982","unstructured":"Olson ST, Shore JD (1982) Demonstration of a two-step reaction mechanism for inhibition of alpha-thrombin by antithrombin III and identification of the step affected by heparin. J Biol Chem 257(24):14891\u201314895","journal-title":"J Biol Chem"},{"issue":"3","key":"9049_CR28","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1042\/bj2180725","volume":"218","author":"DA Lane","year":"1984","unstructured":"Lane DA, Denton J, Flynn AM, Thunberg L, Lindahl U (1984) Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4. Biochem J 218(3):725\u2013732","journal-title":"Biochem J"},{"issue":"4","key":"9049_CR29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0022-5223(19)36215-4","volume":"94","author":"GM Cloyd","year":"1987","unstructured":"Cloyd GM, D\u2019Ambra MN, Akins CW (1987) Diminished anticoagulant response to heparin in patients undergoing coronary artery bypass grafting. The J Thoracic Cardiovas Surgery 94(4):535\u2013538","journal-title":"The J Thoracic Cardiovas Surgery"},{"issue":"3","key":"9049_CR30","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0022-5223(19)37564-6","volume":"85","author":"RA Esposito","year":"1983","unstructured":"Esposito RA, Culliford AT, Colvin SB, Thomas SJ, Lackner H, Spencer FC (1983) Heparin resistance during cardiopulmonary bypass. The role of heparin pretreatment. The J Thoracic Cardiovas Surgery 85(3):346\u2013353","journal-title":"The J Thoracic Cardiovas Surgery"},{"issue":"5","key":"9049_CR31","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/0003-4975(94)91359-5","volume":"57","author":"MH Staples","year":"1994","unstructured":"Staples MH, Dunton RF, Karlson KJ, Leonardi HK, Berger RL (1994) Heparin resistance after preoperative heparin therapy or intraaortic balloon pumping. The Ann Thoracic Surgery 57(5):1211\u20131216","journal-title":"The Ann Thoracic Surgery"},{"issue":"1","key":"9049_CR32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1067\/mhj.2002.123112","volume":"144","author":"IC Gilchrist","year":"2002","unstructured":"Gilchrist IC, Berkowitz SD, Thompson TD, Califf RM, Granger CB (2002) Heparin dosing and outcome in acute coronary syndromes: the GUSTO-IIb experience. Global use of strategies to open occluded coronary arteries. Am Heart J 144(1):73\u201380","journal-title":"Am Heart J"},{"key":"9049_CR33","doi-asserted-by":"crossref","unstructured":"International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb\/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators. Platelet IIb\/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network. Circulation 97(24):2386\u20132395 (1998)","DOI":"10.1161\/01.CIR.97.24.2386"},{"issue":"1","key":"9049_CR34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1023\/A:1022062204490","volume":"14","author":"LK Newby","year":"2002","unstructured":"Newby LK, Harrington RA, Bhapkar MV, Van de Werf F, Hochman JS, Granger CB, Simes RJ, Davis CG, Topol EJ, Califf RM, Moliterno DJ (2002) An automated strategy for bedside aPTT determination and unfractionated heparin infusion adjustment in acute coronary syndromes: insights from PARAGON A. J Thromb Thrombolysis 14(1):33\u201342","journal-title":"J Thromb Thrombolysis"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-006-9049-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-006-9049-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-006-9049-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T17:52:28Z","timestamp":1628358748000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-006-9049-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,13]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,3,13]]}},"alternative-id":["9049"],"URL":"https:\/\/doi.org\/10.1007\/s11239-006-9049-9","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,13]]}}}